Skip to main content
. 2012 Apr;135(4):312–332. doi: 10.1111/j.1365-2567.2011.03544.x

Table 2.

Kinetic profiles of host genes expression modulated by Burkholderia pseudomallei infection in streptozotocin (STZ) -induced diabetes and normoglycaemic models for both liver and spleen

Fold change in transcript at hour post-infection1

Normoglycaemic2 STZ-diabetic


Liver Spleen Liver Spleen




Gene symbol GenBank 16hr 24hr 42hr 16hr 24hr 42hr 16hr 24hr 42hr 16hr 24hr 42hr
Toll-like receptor (TLR) and TLR-related
TLR2 NM_011905 107 72 25 7 8 3 93 23
TLR3 NM_126166 3 2 3 2 2
TLR4 NM_021297 2 3 2
TLR5 NM_016928 −5 −2 −5
TLR6 NM_011604 3
TLR7 NM_133211 3 5 3
TLR13 NM_205820 4 2 4 3
c-FOS NM_010234 5 4 3 7 8 3 4 6
ICAM1 NM_010493 28 45 18 5 3 3 51 12
TRAF6 NM_009424 4 3 2
IRAK2 NM_172161 3 4
IRAK3 NM_028679 30 39 28 6 8 30 6
DUSP11 NM_028099 2 2 2
DUSP16 NM_130447 2 2 2 5 5 2 4
DUSP6 NM_026268 −3
DUSP8 NM_008748 8 4 2 8 3
CD14 NM_009841 106 259 151 10 20 5 171 48
MyD88 NM_010851 8 4 3 4 3 3 5
CD40 NM_170704 3 2
Tab2 NM_138667 2
SOCS1 NM_009896 12 9 6 10 8 5 8 4 3
SOCS2 NM_007706 0 5 4
SOCS3 NM_007707 11 5 13 11 11 6 3
TNFAIP3 (A20) NM_009397 92 63 31 61 8
Cyokines and chemokines
MCP-1/CCL2 NM_011333 28 69 39 39 51 11 90 13 10
MIP1a/CCL3 NM_011337 3 5 39 48 12 4
MIP1b/CCL4 NM_013652 20 30 27 39 35 10 12 8
RANTES/CCL5 NM_013653 11 14 3
MCP-3/CCL7 NM_013654 17 11 12 88 107 40 15 7 19
CCL9 NM_011338 2 4 4 4
CCL12 NM_011331 3 4 13 18 25 27 3 6 6
CCL6 NM_009139 5
CCL24 NM_019577 4 4
CCL11 NM_011330 2 4 13 16 2
CCL17 NM_011332 3 6
CXCL1/KC/GROA NM_008176 27 18 16 103 113 26 13 5 27
CXCL10/IP10 NM_021274 11 16 17 10 17 4 3
CXCL11 NM_019494 3 3
CXCL12 NM_013655 −3 −3 −4 −2
CXCL13 NM_018866 2 4
CXCL16 NM_023158 7 8 4 4 6
CXCL2/GROB NM_009140 7 11 36 41 6 24 4
CXCL5/LIX NM_009141 3 11 20 20 9 8
CXCL9/MIG NM_008599 67 67 57 20 22 41 38 16
MIF XM_147409 3 3 3
CSF1/M-CSF NM_007778 2 3 5 2 2
CSF2 NM_009969 2 7 5 2
CSF3/G-CSF NM_009971 9 15 29 62 24
Immune response
MD2/Ly96 NM_016923 2 3 3
Nfkb1 NM_008689 4 4 3 7 4
Nfkb2 NM_019408 3 3 3
Nfkbia/NFKBI NM_010907 6 5 6 4
Nfkbib/IkB NM_010908 3 3 3
Nfkbie/IkBE NM_008690 3 13 13 13 6
Nfkbiz/INAP NM_030612 24 5 7 8 4
IFNg NM_008337 6 4 148 112 10 4
TNFa NM_013693 3 6 2 9 5 3 11
TNFaip2 NM_009396 8 17 6 31 7 2
TNFaip3 NM_009397 92 63 31 61 8
NOS2 NM_010927 3 11 3 3 27
IRF1 NM_008390 14 19 9 4 4 4 27 12 3 4
IRF5 NM_012057 3 2 4 4
IRF7 NM_016850 5 6 5 7 10 7 3 5 8 6
IRF8 NM_008320 8 6 6 8 13
Jak2 NM_008413 2 2 3 2 4 3
Stat1 NM_009283 11 6 9 4 5 5 6 10 2 3
Stat2 NM_019963 2 4 5 4 3 3 2
Stat3 NM_011486 6 3 3 3 3 3 2
Map3k1 NM_011945 3 2 5 3
Map3k12 NM_009582 −2
Map3k14 NM_016896 3 2 3 2
Map3k8 NM_007746 4 3 2 6 3
Interleukin and interleukin-related
Il10 NM_010548 2 7 4
Il11 NM_008350 3 2 3
Il12rb1 NM_008353 3 4
Il15 NM_008357 5 4 2
Il15ra NM_133836 4 7 4 3 2
Il18 NM_008360 −3
Il18bp NM_010531 14 21 6 12 14 7 11 8
Il1a NM_010554 8 9
Il1b NM_008361 7 8 7 10 9 8 5
Il1r2 NM_010555 2 3 3 10 17 10
Il1rap NM_008364 −6 −5 −4
Il23a NM_031252 11 2 20
Il27 NM_145636 4 4
Il33 NM_133775 3 5 6 7 5 6
Il4i1 NM_010215 15 15
Il6 NM_031168 83 75 6
Il7 NM_008371 4 −3 −3 −2
Il8ra NM_178241 2 2 5
Il8rb NM_009909 3 5 5
Caspases cascades and cell death
caspase 1 NM_009807 2 3 5 3 5
caspase 2 NM_007610 2 3 3 2
caspase 4, caspase 11 NM_007609 7 9 12 5 11 4 9 6
caspase 6 NM_009811 −4 −2 −3
caspase 7 NM_007611 2 2 2 2
caspase 8 NM_009812 2
PARP12 NM_172893 6 5 4 8 8 4 5 5 4
PARP14 NM_145481 13 10 8 6 6 4 9 8 3
Creb3 NM_013497 3 3 4 2
Prkcb1 NM_008855 2
Bid NM_007544 4 8 4 10 5
Tnfrsf1a NM_011609 2 3 3
CD95/FAS NM_007987 4 4 4 5 3 3
Tnfrsf22 NM_023680 3 6 12 10 10
Tnfsf10 NM_009425 2 4 3 4 4 2 3 4 3
1200002N14Rik NM_027878 10 22 23 4 5 5 9 6
Bcl2a1a NM_009742 8 6 8 5 7
Bcl2a1b NM_007534 11 9 12 8 10
Bcl2a1d NM_007536 12 10 13 7 9
Birc2 NM_007465 5 5 6 5 2
Birc3 NM_007464 5 4 5
Cd28 NM_007642 6
Cdkn1a NM_007669 29 12 12 11 13 5 7
Ddit3 NM_007837 5 6 5
Fcgr3 NM_010188 2 5 3
Gadd45b NM_008655 4 4 2 9 9 4
Litaf NM_019980 6 3 3 3 4 3 5 3
Pnp NM_013632 4 3 3 5 5 3 3 2 3
Prkr NM_011163 8 4 3 7 6 4 5 3 2
Ripk2 NM_138952 31 17 6 3 38 5
Scotin NM_025858 3 5 5 4 5
Serpina3g XM_354694 39 30 28 7 8 8 24 30 3
Sox9 NM_011448 6 4 19 3
Tap1 NM_013683 7 7 6 3 3 14 14 2 3
Tap2 NM_011530 6 7 8 6 6 2
Inflammasome-related
NAIP2 NM_010872 2 4 2 2
NLRP3 NM_145827 2
CIIta (NLRA family) NM_007575 4 4 4 7
NALP6/NLRP6 NM_133946 −4 −4 −2
NOD1 NM_172729 3 2 3 3 4 2 3 3
NOD2 NM_145857 3 3 2
P2X4 NM_011026 2 2 3 3
P2ry13 NM_028808 2 2 3 3
P2ry14 NM_133200 2 3 4 4
P2ry2 NM_008773 3 3 4 5 3 6 2
Panx1 NM_019482 6 6 4 6
Ctsz NM_022325 3 3
Ctss NM_021281 4 −2
Ctsc NM_009982 5 3 5
Ctsf NM_019861 −3 −3 −2 −2 −2
Ctsd NM_009983 3
Atg16l2 XM_133655 6 6 5 7 3
Ifi205 NM_172648 4 2 3 3 3 3
Ifi27 NM_029803 2 5 2 3
Ifi30 NM_023065 4 4
Ifi35 NM_027320 3 3 4 2 3 3
Ifi44 NM_133871 5 5 4 3 2 4 5
Ifi47 NM_008330 28 18 15 31 20 3
Type 1 interferon (IFN) related
Oas1g NM_011852 8 22 10 9 6 2 16 17 6
Oas2 NM_145227 2 3 2 9 10 6 2 2
Oasl1 NM_145209 13 22 12 19 18 6 15 15 7
Oasl2 NM_011854 3 4 4 6 7 5 5 6 5
S100a9 NM_009114 27 31 55 31 24
S100a8 NM_013650 26 37 60 33 27
S100a6 NM_011313 6 2 4
S100a11 NM_016740 5 5 2 5 5
Acute-phase proteins
Fgl1 NM_145594 3 3 3
Itih4 NM_018746 2
Cp NM_007752 5 4 6 2 3 4 5 6
Hp NM_017370 5 5 7 5
Pla2g7 NM_013737 2 3 2
Pla2g1b NM_011107 25 29
Lbp NM_008489 7 6 8 8 8
Saa1 NM_009117 13 13 13
Saa2 NM_011314 92 86 74
Saa3 NM_011315 124 121 112 36 91 94 56
Saa4 NM_011316 3 2
Fndc3b NM_173182 6 3 5 3 2 3
Fndc3a NM_207636 3 3
Fth1 NM_010239 2 2
Proteasomal degradation and peptidoglysis
Mmp13 NM_008607 3 6 49 26 10 6 6
Mmp14 NM_008608 6 2 4 3 3
Mmp2 NM_008610 −2 −4 −3
Mmp23 NM_011985 −3 −3
Mmp3 NM_010809 8 41 35
Mmp7 NM_010810 2 3
Mmp8 NM_008611 3 3 10 13
Mmp9 NM_013599 2 4 3 5
Ela2 NM_007919 20 21
Ela1 NM_033612 −7 −12 14 14 −2 −2
Ela3 NM_026419 34 57
Ubd NM_023137 137 192 203 28 33 30 262 218 14
Psma4 NM_011966 2 2
Psma7 NM_011969 3 2
Psmb10 NM_013640 7 10 7 3 4 2 11 9 5
Psmb8 NM_010724 4 9 8 7 8 2
Psmb9 NM_013585 7 7 8 6 7
Psmd10 NM_016883 4 5 5 5 3
Psmd8 NM_026545 2 2
Psmd9 NM_026000 −2
Psme1 NM_011189 4 3 3 3 3 4 3
Prss1 NM_053243 45 67
Prss2 NM_009430 21 28
Prss23 NM_029614 3 2
Ube1dc1 NM_025692 2 2 3 3
Ube1l NM_023738 6 11 8 3 3 2 9 8
Ube2l6 NM_019949 3 3 3 3
Ube2n NM_080560 −2
Ube3b NM_054093 −2
Ube4b NM_022022 2
Complement system
C1r NM_023143 2
C1qa NM_007572 3 3
C1qb NM_009777 3 4
C1qc NM_007574 3 4
C1qtnf1 NM_019959 2 2
C2 NM_013484 2 2 4 5 2
C3 NM_009778 2 3
C4a NM_011413 3
C4b NM_009780 3
C4bp NM_007576 2
C6 NM_016704 −4
C8a NM_146148 −3
C8b NM_133882 −3 −6
C9 NM_013485 −3 −4
C8g XM_130127 −2 −4
Cfb NM_008198 6 9 9
Cfhr1 NM_015780 −3 −2 −6
Masp1 NM_008555 −4 −3 −3
Masp2 XM_358353 −2
Properdin XM_135820 2
Cd55 NM_010016 3
Cd93/c1qr NM_010740 2 4 4 3 3 3
Sftpd NM_009160 2 3 9 2 3 4
Fpr-rs2 NM_008039 13 12 17 7 10 10 10 7
Fpr1 NM_013521 2 6 5
Fibrinolysis and coagulation
Plau NM_008873 5 6
Plaur NM_011113 6 3 12 9 4 4
Plat NM_008872 3 9 3
Klkb1 NM_008455 −3 −28 −5 −15
Klk1 NM_010639 27
Klk1b27 NM_020268 9 22
Klk1b4 NM_010915 −3 10 21
Klk1b5 NM_008456 14 26
Klk1b8 NM_008457 3
Klk4 NM_019928 3
F10 NM_007972 −2 3 6 4
F11 NM_028066 2 2
F13b NM_031164 −7 −4 −3
F3 NM_010171 −2 6 5
F5 NM_007976 −3 −3
F7 NM_010172 −2 −3
F8 NM_007977 −2
Oxidative and anti-oxidative
Gpx2 NM_030677 6 3
Gpx3 NM_008161 2 4 5 3
Gpx7 NM_024198 2 2
Gsta4 NM_010357 −3 −2
Gstm1 NM_010358 −3 −2
Gstm2 NM_008183 2
Gstm3 NM_010359 −2 −2
Gstm4 NM_026764 −3 −5 −3 −4
Gstm6 NM_008184 −4 −2 −3
Gstm7 XM_359308 −5 −3
Gsto1 NM_010362 −3 −2
Gstt1 NM_008185 −5 −6 −3
Gstt2 NM_010361 −2 −3
Gstt3 NM_133994 −6 −2
Gstz1 NM_010363 −3 −2
Mgst3 NM_025569 −3 −3 −11
Gsr NM_010344 2
Sod2 NM_013671 2 5 6 4 2
Tgm2 NM_009373 6 7 7 3 5 5 9 9 5
Noxo1 NM_027988 13 6 6 #N/A
Vnn3 NM_011979 13 25 10 2 27 11
Glycolysis/gluconeogenesis
Hk2 NM_013820 7 4 6 5 6 4 6 4
Hk3 NM_001033245 3 3 4 4 6 4 7
Khk NM_008439 −2 −9 −2
Pfkl NM_008826 3
Pfkp NM_019703 3 3 3
Pgk1 NM_008828 4 3
Pfkm NM_021514 −4 −4 −3 −3
Pgam1 NM_023418 −2
Eno1 NM_023119 −2 2
Eno2 NM_013509 3
Aldoa NM_007438 −4 −3 −3 3
Aldoc NM_009657 −2 −4 −5
Gapdh NM_008084 2 2
Pkm2 NM_011099 5 7 2 3 6 11
Ldha NM_010699 2 2
Pdk4 NM_013743 3
Pdhb NM_024221 −2 −3
Pdk1 NM_172665 −3 −4 −3 −4
Pdk3 NM_145630 2 2 2
Pdk2 NM_133667 −2 −3 −3
Glycogen breakdown
Pygl NM_133198 −10 −4 3
Pgm2 NM_028132 −2 4
Glycogen synthesis
Ugp2 NM_139297 −4 −7 −3 −6
Ugt2b1 NM_152811 −9 −41 −5
Ugt2b34 NM_153598 −6 −2 −6
Ugt3a2 NM_144845 −6 −10 −3
Ugt1a7c NM_201410 −2 −4
Tricarboxylic acid cycle
Aco1 NM_007386 −3 −3
Idh1 NM_010497 −3 −3
Idh3b NM_130884 −2 −2
Idh3a NM_029573 −2
Sdhb NM_023374 −3 −4 −2
Sdhc NM_025321 −2 −2
Sdhd NM_025848 −3 −3
Mdh1 NM_008618 −4 −3 −3
Fatty acid metabolism
Ehhadh NM_023737 −6
Hadh NM_008212 −3 −2 −2
Acat1 NM_144784 −6 −7 −3 −4
Acat2 NM_009338 −2 −3
Acat3 NM_153151 2
Valine, leucine and Isoleucine degradation
Hmgcs1 NM_145942 −2
Hmgcs2 NM_008256 −7 −3
Aldh1a1 NM_013467 −7 −2 −4
Aldh1a7 NM_011921 −2
Aldh1b1 NM_028270 −3 −9 −5
Aldh1l1 NM_027406 −3 −4
Aldh3b1 NM_026316 3 5 3
Aldh4a1 NM_175438 −2 −14 −6 −5
Aldh5a1 NM_172532 −2
Aldh6a1 NM_134042 −3 −2
Aldh8a1 NM_178713 −5 −8 −3
Cytochrome b
Cyp17a1 NM_007809 −3
Cyp1b1 NM_009994 5 5 3
Cyp1a2 NM_009993 −3 −11 −88 −7 −14
Cyp27a1 NM_024264 −2 −5 −2 −2
Cyp2a12 NM_133657 −3
Cyp2a4 NM_009997 −4 −5 −3 −6
Cyp2a5 NM_007812 −8 −10 −8 −4
Cyp2b10 NM_009999 2
Cyp2c29 NM_007815 −6 −49 −3
Cyp2c37 NM_010001 −8 −112 −4
Cyp2c39 NM_010003 −9
Cyp2c50 NM_134144 −11 −22 −3 −3
Cyp2c54 NM_206537 −4 −5 −5 −10
Cyp2c55 NM_028089 −3
Cyp2d10 NM_010005 −3 −3
Cyp2d13 NM_133695 −3 −5 −6 −3
Cyp2d22 NM_019823 −4 −3 2 −2 −3
Cyp2d26 NM_029562 −4 −2 −3
Cyp2d9 NM_010006 −3 −3
Cyp2e1 NM_021282 −3 −12 −2
Cyp2f2 NM_007817 −6 −11
Cyp2g1 NM_013809 −3 −3 −3 −3
Cyp2j9 NM_028979 −3 −3
Cyp3a11 NM_007818 −6 −5 −3
Cyp3a25 NM_019792 −7 −3 −3
Cyp4a10 NM_010011 −7
Cyp4a12 NM_177406 −2 −2
Cyp4a12b NM_172306 −4 −4
Cyp4b1 NM_007823 −2 −3
Cyp4f14 NM_022434 −2 −12 −50 −4
Cyp4f15 NM_134127 −5 −14 −4 −12 −4
Cyp4v3 NM_133969 −3 −6 −3 2 −3 −3
Cyp51 NM_020010 −3
Cyp7a1 NM_007824 −176 −228 −211 −98 −39
Cyp7b1 NM_007825 3 4
Cyp8b1 NM_010012 −154 −137 −68
Miscellaneous
Faah NM_010173 −3 −36 −5 −10
Car1 NM_009799 −2 −4 −5 −6 −2 −6 −7
Car13 NM_024495 4 7 8 5 8 4 4 3
Car14 NM_011797 −4 −13 −10 −3 −4
Car2 NM_009801 −11
Car3 NM_007606 −6 −263 −4 −34
Car4 NM_007607 2 12 5 2
Car5a NM_007608 −7 −26 −11 −19
Akr1b3 NM_009658 3
Akr1b7 NM_009731 4
Akr1c14 NM_134072 −8 −23 −12 −26
Akr1c19 NM_001013785 −5 −8 −7 −6
Akr1c6 NM_030611 −17 −24 −5
Akr1e1 NM_018859 −3 −2
Akr7a5 NM_025337 −4 −2
Ddc NM_016672 −14 −31 −4 −13
Apoa2 NM_013474 −3 −6
Apoa5 NM_080434 −24 −11
Aqp1 NM_007472 −3 −4 −12
Aqp11 NM_175105 −5 −5 −2 −3 −2
Aqp4 NM_009700 −3 −2 −2
Aqp8 NM_007474 −6 −6
Aqp9 NM_022026 −5 −24 −4 −4 −8
Arg1 NM_007482 −5 3 5 −4
Arg2 NM_009705 19 11 4 6 3 12
1

Modulated transcripts are classified according to functional groups. Only genes with a more than twofold change in B. pseudomallei-infected liver or spleen versus uninfected control tissue are shown; ‘–’, no significant change in gene expression.

2

Data adopted from our recent work on genome-wide expression profiling of a murine acute melioidosis model.18